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A series of novel 1-amino dibenzo[b,d]furan derivatives have been synthesised via 1,3-dinitrophenol with iodophenol 
compound. The chemical structures of the compound have been elucidated by 1H and 13C NMR. The mass of the 
synthesized compounds has been estimated by LCMS. The functional groups present in the title compound are revealed 
from FT-IR and confirmed by elemental analysis. These compounds have also been screened for in vitro antibacterial and 
antifungal activities. 
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The use of metal complexes for biomedical 
applications is an important one. In this process, the 
macrocycles were used as chelating agents for metal 
ions. They play a vital role as fluorescent sensors and 
neuroimaging agents. One among them is benzofuran 
which is a fluorescent molecule that has attracted the 
attention of researchers as it is able to bind to the 
amyloid plaques formed during Alzheimer’s disease. 
Dibenzofuran bearing compounds, an analog of 
benzofuran ring, have been reported to exhibit a 
great variety of biological effects, including 
thrombosis and anticholinesterase activity
1,2
. Isolation 
of several Gram-negative or Gram-positive bacteria 
able to mineralize non-halogenated dibenzofuran 
was reported earlier
3
. Lichen secondary metabolite 
isolated from Cladonia substellata, a derivative of 
dibenzofuran, shows antimycobacterial activity. 
However, it cannot be used as a drug because of its 
weak potency. Synthetic analogue derived from 




In most of the naturally occurring molecules, there 
is a lack of biological activity and also the isolation is 
a tedious procedure. Structure activity relationship 
(SAR) studies showed the vital role of 
dibenzo[b,d]furan moiety on their pharmacological 
properties
7,8
. Therefore it is envisaged to synthesize a 
library (series) of small triazolyl derivatives of 
dibenzo[b,d]furan by Huisgen’s1,3-dipolar 
cycloaddition reaction and a view to study their anti-




The 1,3-dinitrobenzene, 2-iodophenol, potassium 
tert-butoxide, pyridine and dimethoxyethane were 
purchased from Sigma-Aldrich, India and used 
without purification. Methanol, dichloromethane 
(DCM), ethyl acetate, hexane, Con.HCl, SnCl2 and 
triethylamine were purchased from Sigma-Aldrich. 
Dry solvents were supplied by Spectrochem. Reagent 
and solvent were purchased from commercial sources 
and used without further purification unless otherwise 
noted. 
The melting points were recorded on SRS Optimelt 
and are uncorrected. 
1
HNMR spectra were recorded 
on a 400 MHz Varian spectrometer and 
13
CNMR 
spectra were recorded on a 100 MHz Bruker 
spectrometer with tetramethylsilane (TMS) internal 
standard. Mass spectra were recorded by using 
Shimadzu mass spectrometer. The FT-IR spectra were 
recorded by KBr pellet technique with the help of a 
Perkin-Elmer spectrum 100 series spectrophotometer. 
Column chromatography was performed with silica 
gel 60-120 mesh. All the reactions were monitored by 
thin layer chromatography (TLC) plates and their 
spots were visualized by exposing them to UV lamp, 




KMnO4 or iodine chamber. The elemental analysis 
has been obtained using a Varian instrument VARIO 
EL3 series analyzer. 
 
Synthesis and characterization of the compounds 
 
Synthesis of 1-nitro dibenzo[b,d]furan, 3 
A solution of 1,3-dinitrobenzene 1 (5 g, 29.74 
mmol, 1 eq) and 2-iodophenol 2 (6.5 g, 29.74 mmol, 1 
eq) was prepared. Now dimethoxyethane (20 mL) and 
Pyridine (10 mL) were added and stirred again by 
keeping the temperature at 25°C. The Reaction 
mixture was stirred for 10 min and then potassium 
tertiary butoxide (6.7 g, 59.48 mmol, 2 eq) was added 
and heated to 100° C for 16 hrs. The progress of the 
reaction was monitored by TLC. The reaction mixture 
was cooled to room temperature and quenched with 
cold water and extracted with ethyl acetate (2*50 
mL), the organic layer was dried (MgSO4) and 
concentrated. The residue was purified by column 
chromatography to get 1-nitrodibenzo [b,d]furan 3 (3 
g, yield 47%, LCMS: 95.5% purity), m.pt.124-135°C. 
IR (KBr, cm
-1
): νmax 1518 (N=O), 1690, 1441-1630 
(C=C), 973-1150 (C-O, C-N). 
1
HNMR (400 MHz, 
DMSO-d6, ppm): δ 8.84 (t, 1H, J=8.1Hz, Ar-CH), 
8.53 (d, 1H, J=7.6Hz, Ar-CH), 8.52-8.25 (m, 3H, Ar-
3CH), 7.99-7.58 (m, 2H, Ar-2CH). 
13
CNMR (100 
MHz, DMSO-d6, ppm): δ 112.52, 118.16, 119.09, 
120.42, 120.57, 124.36, 125.86, 128.20, 129.86, 
130.62, 132.08, 143.02. For C12H7NO3, calculated: 
67.61% C, 3.31% H, 6.57% N and 22.51% O. found: 
67.40% C, 3.39% H, 6.86% N, and 22.18% O. LCMS 
[M+1] 
+
: m/z 214.19. 
 
Synthesis of 1-amino dibenzo[b,d]furan, 4 
Stannous chloride ( 4 g, 21.12mmol, 1.5eq ) was 
added To a stirred solution compound 3 (3 g, 14.08 
mmol) in Conc.HCl (25 mL) at 0° C, in portions wise. 
Reaction was stirred for 4hrs at 0° C. The progress of 
the reaction was monitored by TLC. After the 
completion, reaction was quenched with ice water. 
Reaction mixture was extracted with ethyl acetate, 
dried (MgSO4) and concentrated. Crude residue was 
purified by column chromatography to get 1-amino 
dibenzo[b,d]furan 4 (2 g, yield : 77.8%). LCMS: 
95.7% (purity), m.pt.85-117°C. IR (KBr, cm
-1
): νmax 
3368 (NH2), 1430-1577 (C=C), 1352-1197 (C-O, C-
N). 
1
HNMR (400 MHz, DMSO-d6, ppm): δ 8.27 (t, 
1H, J=8.4Hz, Ar-CH), 7.61 (d, 1H, J=8Hz, Ar-CH), 
7.43-7.39 (m, 2H, Ar-2CH), 7.22 (t, 1H, J=8Hz, Ar-
CH), 6.85 (d, 1H, J=7.6Hz, Ar-CH), 6.64 (d, 1H, 
J=8Hz, Ar-CH), 5.87 (s, 2H, NH2). 
13
CNMR (100 
MHz, DMSO-d6, ppm): δ 99.14, 108.63, 109.52, 
111.10, 122.03, 122.99, 124.20, 125.85, 128.74, 
144.92, 154.81, 157.35. For C12H9NO, calculated: 
78.67% C, 4.95% H, 7.65% N and 8.73% O. found: 
78.70% C, 4.79% H, 7.86% N and 8.58% O. LCMS 
[M+1] 
+
: m/z 184.21. 
 
Representative procedure to prepare amide 
derivative, 5a-e 
To a solution of 1-amino dibenzo[b,d]furan 4 (100 
mg, 0.546 mmol) in DCM (2mL), TEA (0.5 mL, 1.09 
mmol, 2 eq) was added. At 0°C corresponding acid 
chloride was added drop-wise and stirred for 5hrs. 
The progress of the reaction was monitored by TLC. 
After the completion, ice water was added then the 
organic layer was separated, dried (MgSO4) and 
concentrated. The crude residue was recrystallized 
from diethyl ether to give compound 5a-e. 
 
Synthesis of N-(dibenzo[b,d]furan-1-yl)acetamide, 
5a 
Yield: 80 mg, 65%, off-white solid, LCMS: 95.3% 
(purity), m.pt.197-212°C. IR (KBr, cm
-1
): νmax 3257 
(amide N-H), 1650 (C=O), 1474-1418 (C=C), 1199-
1047 (C-O, C-N). 
1
HNMR (400MHz, DMSO-d6, 
ppm) : δ 10.15 (s, 1H, N-H), 7.94 (d, 1H, J=8.4Hz, 
Ar-CH), 7.71 (d, 1H, J=7.2Hz, Ar-CH), 7.50-7.40 (m, 
3H, Ar-3CH), 7.42 (t, 1H, J=7.2Hz, Ar-CH), 7.35 (d, 
1H, J=8Hz, Ar-CH), 2.23 (s, 3H, CO-CH3). 
13
CNMR (100 MHz, DMSO-d6, ppm): δ 39.34, 40.60, 
106.11, 107.12, 111.70, 116.22, 123.29, 123.40, 
124.60, 127.75, 127.86, 134.12, 145.62, 168.51. For 
C14H11NO2, calculated: 74.65% C, 4.92% H, 6.22% N 
and 14.21% O. found: 74.75% C, 4.96% H, 6.27% N 
and 14.20% O. LCMS [M+1] 
+
: m/z 226.25. 
 
Synthesis of N-(dibenzo[b,d]furan-1-yl)benzamide, 
5b 
Yield: 85 mg, 51%, white solid, LCMS: 95.4% 
(purity), m.pt.162-171°C. IR (KBr, cm
-1
): νmax 3245 
(amide N-H), 1690 (C=O), 1521-1425 (C=C), 1268-
1125 (C-O, C-N). 
1
HNMR (400 MHz, DMSO-d6, 
ppm): δ 7.86 (d, 1H, J=8Hz, Ar-CH), 7.82 (t, 1H, 
J=6.8Hz, Ar-CH), 7.83-7.77 (m, 5H, Ar-5CH), 7.71 
(d, 1H, J=8.4Hz, Ar-CH), 7.56 (t, 1H, J=7.2Hz, Ar-
CH), 7.50 (d, 1H, J=8Hz, Ar-CH), 7.44 (t, 1H, 
J=7.6Hz, Ar-CH), 7.42 (t, 1H, J=7.8Hz, Ar-CH), 7.34 
(d, 1H, J=8Hz, Ar-CH). 
13
CNMR (100 MHz, DMSO-
d6, ppm): δ 40.60, 112.29, 112.62, 121.90, 124.29, 
126.45, 127.65, 128.66, 128.89, 129.04, 129.27, 
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129.33, 129.73, 132.21, 133.35, 134.30, 145.08, 
156.03, 173.03. For C19H13NO2, calculated: 79.43% 
C, 4.56% H, 4.88% N and 11.14% O. found: 79.40% 






Yield: 120mg, 60% white solid, LCMS: 95.3% 
(purity). m.pt. 65-72°C. IR (KBr, cm
-1
): νmax 3369
(amide N-H), 1651 (C=O), 1594-1306 (C=C), 1264-
996 (C-O, C-N). 
1
HNMR (400 MHz, DMSO-d6, ppm)
:δ 8.25 (d, 2H, J=7.2Hz, Ar-2CH), 7.60 (d, 2H, 
J=8.4Hz, Ar-2CH), 7.42-7.38 (t, 2H, J=7Hz, Ar-
2CH), 7.35-7.31 (t, 2H, J=7.6Hz, Ar-2CH), 7.20-7.16 
(t, 2H, J=7.8Hz, Ar-CH), 6.83-6.81 (d, 1H, J=8Hz, 
Ar-CH), 6.61-6.59 (d, 2H, J=8Hz, Ar-2CH), 5.84(s, 
4H). 
13
CNMR (100 MHz, DMSO-d6, ppm): δ 39.97,
40.60, 99.14, 108.64, 109.52, 111.10, 122.03, 122.99, 
124.21, 124.88, 125.85, 126.01, 127.34, 127.90, 
128.21, 128.74, 129.02, 129.40, 129.54, 131.11, 
134.34, 136.05, 144.92, 157.35, 164.13. For 
C25H17NO2, calculated: 82.63% C, 4.72% H, 3.85% N 
and 8.81% O. found: 82.67% C, 4.70% H, 3.87% N 
and 8.83% O. LCMS [M+1] 
+
: m/z 363.42. 
Synthesis of N-(dibenzo[b,d]furan-1-yl)methane 
sulphonamide, 5d 
Yield: 95mg, 67%, 0ff-white solid, LCMS: 95.3% 
(purity), m.pt.158-162°C. IR (KBr, cm
-1
): νmax 3019
(amide N-H), 1451 (C=C), 1361-1156 (sulfonamide) 
1048-877 (C-O, C-N). 
1
HNMR (400 MHz, DMSO-d6,
ppm): δ 8.22 (d, 1H, J=7.2Hz, Ar-CH), 7.93 (d, 1H, 
J=7.6Hz, Ar-CH), 7.80 (d, 1H, J=8.4Hz, Ar-CH), 
7.67 (d, 1H, J=8Hz, Ar-CH), 7.64 (t, 1H, J=7.8Hz, 
Ar-CH), 7.62 (t, 1H, J=7.4Hz, Ar-CH), 7.51 (t, 1H, 
J=7.4Hz, Ar-CH), 5.75 (s, 1H, -NH), 2.50 (s, 3H, -
CH3). 
13
CNMR (100 MHz, DMSO-d6, ppm): δ 39.97,
43.70, 112.47, 114.47, 121.88, 123.03, 124.76, 
127.30, 127.84, 128.24, 129.07, 139.12, 156.51. For 
C13H11NO3S, calculated: 59.76% C, 4.24% H, 5.36% 
N, 18.37% O and 12.27% S. found: 59.66% C, 4.28% 
H, 5.39% N, 18.39% O and 12.28% S. LCMS [M+1] 
+
: m/z 261.30. 
Synthesis of N-(dibenzo[b,d]furan-1-yl)phenyl 
methane sulphonamide, 5e 
Yield: 120mg, 65%, white solid, LCMS: 95.3% 
(purity), m.pt.112-143°C. IR (KBr, cm
-1
): νmax 3429
(amide N-H), 1496-1429 (C=C), 1264-1162 
(sulfonamide), 1054-844 (C-O, C-N). 
1
HNMR (400 
MHz, DMSO-d6, ppm) : δ 8.24 (d, 2H, J=8Hz, Ar-
CH), 7.60 (d, 1H, J=8.4Hz, Ar-CH), 7.42 (t, 2H, 
J=7.6Hz, Ar-CH), 7.35 (t, 2H, J=7.2Hz, Ar-CH), 7.20 
(t, 2H, J=7.8Hz, Ar-CH), 6.83 (d, 2H, J=8Hz, Ar-
CH), 6.61 (d, 1H, J=8Hz, Ar-CH), 5.84 (s, 2H, -CH2), 
5.32 (s, 1H, -NH). 
13
CNMR (100 MHz, DMSO-d6,
ppm): δ 39.97, 40.60, 59.55, 99.14, 108.64, 111.10, 
122.03, 122.99, 124.21, 125.85, 128.74, 129.12, 
129.45, 133.01, 134.11, 144.92, 145.8, 154.35, 
157.35. For C19H15NO3S, calculated: 67.64% C, 
4.48% H, 4.15% N, 14.23% O, 9.50% S. found: 
67.67% C, 4.43% H, 4.13% N, 14.25% O, 9.53% S. 
LCMS [M+1] 
+
: m/z 337.05. 
Results and Discussion 
Chemistry aspect 
The synthesis of the N-(dibenzo[b,d]furan-1-yl) 
substituted amides 5a-e were carried out as shown 
in Scheme I. The starting materials were 1, 3-
dinitrobenzene and 2-iodophenol in dimethoxyethane 
(DME). The obtained intermediate product 1-nitro 
dibenzo[b,d]furan 3 and 1-amino dibenzo[b,d]furan 4 
Scheme I 




was then refluxed. The amine derivatives in 
dichloromethane (DCM), triethylamine (TEA) with 
an added acid chloride to get desired compounds  
5a-e. 
In the IR spectra, the characteristic N–H bands  
and amide functions were observed at in the range 
3245–3369 cm
-1
. In the NMR spectra, peaks at about 
2.22–3.62 ppm, 2.50–2.54 ppm and 10.15–10.17 ppm 
were seen assigning to CH3, CO-CH3, and NH protons 
respectively. M+1 peaks in mass spectra were agreed 
with the calculated molecular weight of the title 
compounds 5a-e. The weight percentage of C, H and 
N elements obtained from elemental analysis agree 
with theoretically calculated values of the compounds. 
According to LCMS analysis, purity ratio was found 




Collection of microorganisms 
The microorganisms such as Bacillus cereus, 
Salmonella typhi, Staphylococcus aureus (S. aureus) 
and fungal development of Aspergillus niger, 
Candida albicans, Candida kefyr were obtained from 
Micro lab, Institute of Research and Technology, 
Arcot, Vellore, Tamil Nadu, India. In the present 
study, antimicrobial organisms were used for testing 
microbial activities. The bacteria were maintained  
on nutrient broth (NB) at 37°C and fungus was 
maintained on potato dextrose agar (PDA) at 28°C. 
 
Antimicrobial activity 
The synthesized N-(dibenzo[b,d]furan-1-yl)acetamide 
5a, N-(dibenzo[b,d]furan-1-yl)benzamide 5b,  
N-(dibenzo[b,d]furan-1-yl)-[1,1’-biphenyl]-4-
carboxamide 5c, N-(dibenzo [b,d]furan-1-
yl)methanesulfonamide 5d and N-(dibenzo[b,d]furan-
1-yl)phenyl methanesulfonamide 5e compounds are 
subjected to in vitro antibacterial and antifungal 
activity using agar diffusion (Table I). A 20 mL of 
nutrient agar and PDA medium are used for each 
sterile Petri plate (90 mm). It is left for solidification. 
And then 100 μL of bacterial apprehension was 
spread on the plates. After 5 minutes, a sterile filter 
paper disc (6 mm) containing 5 μL of the compound 
was placed on the surface of each plate. Now the 
plates were incubated at 37°C for 24 h bacterial 
development and at 28°C for 48 h for fungal 
production. The antimicrobial activities of various 
compounds are examined by measuring the diameter 
of the inhibition zone (DIZ) in mm. ciprofloxacin and 
amphotericin B were served as reference. 
 
Conclusions 
A series of novel 1- amino dibenzo[b,d]furan 
derivatives were synthesised from the preparation of 
1,3-dinitrophenol with 2-iodophenol compound. The 





CNMR establish the 
chemical structures of the synthesized compound. 
Among the series of synthesized compounds, 
compound 5c shows better antibacterial and 
antifungal activities. Hence compound 5c can be used 
for further studies and pharmacological applications. 
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